TERROSA sol inj 250 mcg/ml kit stylo+cartou 2.4 ml

7680668200030 CH-66820 H05AA02 07.99.0.

Reimbursement limitations:

FORSTEO 2

Pour un traitement en deuxième ligne de femmes post-ménopausées ou d'hommes qui développent de nouvelles …

TERROSA sol inj 250 mcg/ml kit stylo+cartou 2.4 ml
TERROSA sol inj 250 mcg/ml kit stylo+cartou 2.4 ml
TERROSA sol inj 250 mcg/ml kit stylo+cartou 2.4 ml
1 / 3
google

Details

Product number
6682001
CPT
-
Packaging group
1
Unit
Set
Composition
teriparatidum ADNr 250 µg, acidum aceticum glaciale, natrii acetas trihydricus, mannitolum, conserv.: metacresolum 3 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

Articles (1)

Terrosa, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/09/2025
Patient information leaflet
Français
23/09/2025
Patient information leaflet
Italien
23/09/2025
Professional SmPC
Allemand
23/09/2025
Professional SmPC
Français
23/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.028 MG Substance HBESI

Reimbursement information

Public price
CHF 278.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2019

Authorization holder

Gedeon Richter (Schweiz) AG

1202 Genève

Authorization information

Swissmedic authorization number
66820
Drug name
Terrosa, Injektionslösung
Galenic form
LSINJ
ATC Code
H05AA02
Authorization status
Z
Dispensation category
B
First authorization
04/12/2018
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Postmenopausale Osteoporose bei Frauen; primäre und hypogonadale Osteoporose bei Männern. Glukokortikoid-induzierte Osteoporose bei Erwachsenen mit erhöhtem Frakturrisiko.

Packaging details

Description (FR)
TERROSA sol inj 250 mcg/ml kit stylo+cartou 2.4 ml
Description (DE)
TERROSA Inj Lös 250 mcg/ml Kit Pen+Patrone 2.4 ml
Market launch
04/12/2018
Narcotic (BTM)
No

Available generics

Teriparatid-Mepha, Injektionslösung im Fertigpen
CHF 225.60
View

Other packaging sizes

TERROSA sol inj 250 mcg/ml cartouche 2.4 ml
1 STU
View